MedTrace Logo

ANC COVID-19 Surveillance

NCT07021807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9111

Last updated 2025-06-15

No results posted yet for this study

Summary

The purpose of this observational study is to determine the seroprevalence of SARS-CoV-2 antibodies in the community with pregnant women aged 15-49 years attending first antenatal care as the sentinel population. Further, the study seeks:

* To determine the feasibility and acceptability of SARS-CoV-2 antibody tests among pregnant women
* To estimate the prevalence of HIV-COVID 19 co-infection among pregnant women aged 15-49 years
* To determine sociodemographic factors associated with SARS-CoV-2 seropositivity among pregnant women
* To compare trends in seroprevalence among pregnant women with routine surveillance data to determine if ANC sentinel surveillance is a viable surveillance strategy for SARS-CoV-2

The main question it aims to answer is:

\- What is the seroprevalence of antibodies to SARS-CoV-2 among pregnant women attending first ANC visit in Zambia?

Participants will be expected to give consent to participating in the study on the day of their first antenatal visit. They should allow the collection of a dried blood spot for SARS-CoV-2 antibody test.

Conditions

  • SARS-CoV-2 Seroprevalence

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-06
Primary Completion
2022-09-30
Completion
2023-03-30

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07021807 on ClinicalTrials.gov